Liver International · 2006 · 40 citations · 8 references
In this non-randomized study, survival after MARS was related to the availability of transplant, and in patients where living or deceased donor transplant was unavailable, MARS was of little benefit. Randomized-controlled trials on MARS((R)) are urgently needed to clarify its clinical utility.
8
Steffen Mitzner, Jan Stange, Sebastian Klammt et al. · Liver Transplantation · 2000 · 606 citations · Full text